Our Pricing

What's Better Mounjaro or Ozempic? A UK Clinical Comparison

Published: 11 September 2026

When patients ask what's better Mounjaro or Ozempic, the answer depends on individual weight loss goals, tolerance, and clinical history. Both medications are GLP-1 receptor agonists licensed in the UK for type 2 diabetes management, though Mounjaro (tirzepatide) also targets GIP receptors, offering a dual incretin action. Clinical trial data suggests Mounjaro may deliver greater average weight loss, but Ozempic (semaglutide) remains highly effective with a well-established safety profile [1][2].

What's Better Mounjaro or Ozempic for Weight Loss Results?

In head-to-head comparisons, what's better Mounjaro or Ozempic often comes down to weight loss magnitude. The SURPASS-2 trial directly compared tirzepatide and semaglutide in adults with type 2 diabetes, finding that participants on tirzepatide 15mg lost an average of 11.2kg over 40 weeks, compared to 5.7kg on semaglutide 1mg [1]. This dual GIP/GLP-1 mechanism appears to enhance appetite suppression and metabolic control more robustly than GLP-1 agonism alone.

However, Ozempic's STEP trials demonstrated substantial weight loss in non-diabetic populations, with participants losing up to 15% of baseline body weight on semaglutide 2.4mg (marketed as Wegovy for weight management) [2]. While Ozempic for diabetes is capped at 1mg weekly, many UK prescribers recognise its efficacy at lower doses. Both medications require gradual dose escalation to minimise gastrointestinal side effects, and individual response varies considerably.

From a clinical perspective, Mounjaro may offer a slight edge in average weight loss outcomes, but Ozempic's longer market presence and broader real-world data provide reassurance for many patients. Both require prescription assessment by a UK-registered clinician, and results depend on adherence, lifestyle modifications, and metabolic baseline [3].

What's Better Mounjaro or Ozempic in Terms of Side Effects?

When evaluating what's better Mounjaro or Ozempic for tolerability, both share a similar side effect profile dominated by gastrointestinal symptoms. Nausea, diarrhoea, constipation, and abdominal discomfort are common during dose escalation, typically resolving within 4-8 weeks as the body adapts [4]. In clinical trials, approximately 20-30% of participants on tirzepatide reported nausea, compared to 15-25% on semaglutide, though severity and duration varied.

Mounjaro's dual incretin action may slightly increase gastrointestinal burden in sensitive individuals, but many patients tolerate it well with slow titration. Ozempic's established dosing protocols and extensive post-marketing surveillance offer predictability, which some prescribers favour for first-line therapy. Both medications carry MHRA warnings regarding potential thyroid C-cell tumours (observed in rodent studies, not confirmed in humans) and pancreatitis risk, necessitating careful patient selection [5].

Neither medication is inherently 'better' for side effects — individual tolerance dictates success. Our superintendent pharmacist Tarun Kumar advises patients to maintain hydration, eat smaller meals, and report persistent symptoms promptly. Dose adjustments or switching between agents may optimise tolerance while preserving efficacy.

Managing Gastrointestinal Side Effects with Mounjaro and Ozempic

Practical strategies include eating slowly, avoiding high-fat meals, and spacing doses consistently. If nausea persists beyond 8 weeks on either medication, clinical review is essential. Some patients find Ozempic's once-weekly injection easier to schedule, while others prefer Mounjaro's potentially greater efficacy despite transient discomfort. Both require individualised management under UK prescriber supervision.

What's Better Mounjaro or Ozempic for UK Availability and Cost?

Cost considerations influence what's better Mounjaro or Ozempic for many UK patients. At Cured Pharmacy, Mounjaro is available from £124.99 following online clinical assessment, with transparent upfront pricing and £20 off your first order using code Weightlossnew. Ozempic pricing varies by dose and supplier, but both medications require private prescription in the UK for weight management indications, as NHS access remains limited to type 2 diabetes or specific obesity criteria via specialist referral.

Mounjaro's UK launch in 2023 expanded treatment options, though supply has occasionally been constrained due to high demand. Ozempic, available since 2019, benefits from more established distribution networks. Both are manufactured by reputable pharmaceutical companies (Eli Lilly for Mounjaro, Novo Nordisk for Ozempic) and licensed by the MHRA for safety and efficacy.

When weighing what's better Mounjaro or Ozempic financially, consider total treatment duration, dose escalation schedules, and potential for dose maintenance. Our clinical team provides personalised cost-benefit analysis during your free online consultation, ensuring you understand long-term commitment before starting therapy.

What's Better Mounjaro or Ozempic: Dosing and Administration Differences

Understanding what's better Mounjaro or Ozempic requires comparing their dosing regimens. Mounjaro is initiated at 2.5mg weekly, escalating every 4 weeks through 5mg, 7.5mg, 10mg, 12.5mg, to a maximum of 15mg, allowing fine-tuned titration [6]. Ozempic starts at 0.25mg weekly for 4 weeks, then 0.5mg, with optional increases to 1mg (or 2mg in some formulations) depending on glycaemic control and tolerance.

Both are administered as subcutaneous injections into the abdomen, thigh, or upper arm using pre-filled pens. Injection technique is straightforward, and most patients self-administer confidently after initial training. Mounjaro's broader dose range offers flexibility for patients requiring higher doses to achieve target weight loss, while Ozempic's simpler escalation may suit those preferring fewer dose changes.

Missed doses should be administered within 4 days for Mounjaro or 5 days for Ozempic; beyond that, skip the missed dose and resume the regular schedule. Consistency is key — both medications work best when injected on the same day each week. Your UK prescriber will tailor the escalation schedule to your tolerance and response.

Injection Technique and Storage for Mounjaro and Ozempic

Store both medications in the refrigerator (2-8°C) until first use, then may be kept at room temperature (up to 30°C) for up to 21 days (Ozempic) or 21 days (Mounjaro). Rotate injection sites to prevent lipodystrophy. Dispose of used pens in a sharps container, available free from most UK pharmacies. Proper storage and technique maximise medication stability and absorption.

What's Better Mounjaro or Ozempic for Long-Term Weight Maintenance?

Long-term data on what's better Mounjaro or Ozempic for sustained weight loss is still emerging. The SURMOUNT-4 trial demonstrated that participants maintaining tirzepatide after initial weight loss sustained an average 5.5% additional reduction over 52 weeks, compared to 14% regain in the placebo group [7]. Similarly, the STEP-4 trial showed semaglutide users maintained weight loss significantly better than those discontinuing treatment [8].

Both medications appear to require ongoing use for sustained benefit, as weight regain is common upon cessation. This reflects their mechanism — they modulate appetite and glucose metabolism rather than permanently altering metabolic set points. UK prescribers typically recommend indefinite therapy for patients achieving meaningful weight loss, subject to ongoing tolerance and clinical benefit.

When considering what's better Mounjaro or Ozempic for maintenance, factor in your willingness to commit to weekly injections long-term, cost sustainability, and individual response. Our pharmacy team provides ongoing support, dose optimisation, and re-assessment to ensure your treatment remains effective and safe over months to years.

What's Better Mounjaro or Ozempic: Making the Right Choice for You

Ultimately, what's better Mounjaro or Ozempic is a personalised clinical decision. Mounjaro may be preferable if you prioritise maximal weight loss potential and tolerate gastrointestinal side effects well. Ozempic suits patients seeking proven efficacy with extensive real-world safety data and simpler dose escalation. Both require prescription assessment, and neither is suitable for everyone — contraindications include personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or severe gastrointestinal disease.

At Cured Pharmacy, our UK-registered clinical team evaluates your medical history, weight loss goals, and tolerance profile during a free online consultation under 3 minutes. We provide transparent pricing from £124.99 for Mounjaro, with £20 off your first order using code Weightlossnew, and discreet next-day delivery across the UK. All medications are UK-licensed and dispensed by GPhC-registered pharmacists.

Whether you choose Mounjaro or Ozempic, success depends on adherence, lifestyle modification, and regular clinical review. We support you throughout your weight loss journey with expert guidance, dose adjustments, and ongoing monitoring to optimise outcomes safely and effectively.

Starting Your Weight Loss Journey with Cured Pharmacy

Begin your assessment today to determine which medication aligns with your clinical profile and goals. Our superintendent pharmacist Tarun Kumar and clinical team ensure every prescription is appropriate, safe, and tailored to your needs. With lowest UK prices guaranteed, discreet packaging, and expert support, Cured Pharmacy makes accessing effective weight loss treatment straightforward and affordable.

Scientific References

1. Frías, J. P., Davies, M. J., Rosenstock, J., Pérez Manghi, F. C., Fernández Landó, L., Bergman, B. K., ... & SURPASS-2 Investigators. (2021). Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes. New England Journal of Medicine, 385(6), 503-515. [accessed 11 September 2026]
2. Wilding, J. P., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., ... & STEP 1 Study Group. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002. [accessed 11 September 2026]
3. Medicines and Healthcare products Regulatory Agency. (2023). Mounjaro (tirzepatide): Summary of Product Characteristics. MHRA. [accessed 11 September 2026]
4. Nauck, M. A., D'Alessio, D. A. (2022). Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction. Cardiovascular Diabetology, 21(1), 169. [accessed 11 September 2026]
5. Medicines and Healthcare products Regulatory Agency. (2022). GLP-1 receptor agonists: Reports of diabetic ketoacidosis when concomitant insulin was rapidly reduced or discontinued. Drug Safety Update, 15(8). [accessed 11 September 2026]
6. Electronic Medicines Compendium. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen. Summary of Product Characteristics. EMC. [accessed 11 September 2026]
7. Aronne, L. J., Sattar, N., Horn, D. B., Bays, H. E., Wharton, S., Lin, W. Y., ... & SURMOUNT-4 Investigators. (2024). Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity: the SURMOUNT-4 randomized clinical trial. JAMA, 331(1), 38-48. [accessed 11 September 2026]
8. Rubino, D., Abrahamsson, N., Davies, M., Hesse, D., Greenway, F. L., Jensen, C., ... & STEP 4 Investigators. (2021). Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: the STEP 4 randomized clinical trial. JAMA, 325(14), 1414-1425. [accessed 11 September 2026]
9. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 11 September 2026.
10. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 11 September 2026.
11. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 11 September 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.